L-carnitine ilegal in Canada?

Why is L-carnitine ilegal in Canada?
i think that really sucks personally

Wait... its illegal in Canada???
 
Isn't that the stuff thats in alot of the leading energy drinks? like Monster and SoBe? What's wrong with the stuff..haha.. I ersonally, drink a lot of energy drinks.

7/14/06 STACK:

XCEED
ON's 100% Whey
Vitamin C
Multi-Vitamin
--Deciding: Basic Cuts or Melting Point--

Currently:
16y.o.
193lbs
6ft 3
BF%- Soon

yup it is well at least thats what i was told by a couple of people in health store because i was looking for it.
 
but i was wondering could you have it shipped to canada from the U.S or no?

I just read on Bodybuilding.com that NO2 was illegal in Canada as well.  Man, that's crazy...I had no idea.

I found this site.....

http://www.athletes.com/store/help/illegal.htm

Forum Rules & Guidelines

[image]http://www.bodybuildingjournal.com/bodybuilding/images/bbjbanner.gif[/image]

A good buddy of mine lives in Canada and he told me that the laws are real strick up there compared to the U.S.  But he said that he orders hardcore supps from a few of the U.S. websites without any problem.

I wonder why the laws are so different?

why would vitamin-k be illegal in canada?

IM BACK AND BETTER THAN EVER!!!!!

Health Canada is one strict piece of crap !
Believe me...we were the latest contry to approve anti-baby pills !

Guess why !!?

Everyone is entitled to be stupid, but some abuse the privilege.

This regulatory amendment to Schedule F, Part II, to the Food and Drug Regulations creates nonprescription status for:
(1) Vitamin K1 and K2 in oral dosage forms for use in humans when the maximum recommended daily dose is equal to or less than 120 micrograms (0.120 milligrams); and (2) Vitamin K1 and K2 in products intended for external use in humans. A related amendment adds vitamin K1 and K2 to item 3 of Schedule 1 to the Natural Health Products Regulations. However, the dosage forms and strengths of vitamin K remaining on Schedule F to the Food and Drug Regulations would not be considered to be natural health products pursuant to subsection 2(2) of the Natural Health Products Regulations.
Schedule F is a list of medicinal ingredients, the sale of which is controlled under sections C.01.041 to C.01.049 of the Food and Drug Regulations. Part I of Schedule F lists ingredients that require a prescription for human use and for veterinary use. Part II of Schedule F lists ingredients that require a prescription for human use, but do not require a prescription for veterinary use if so labelled or if in a form unsuitable for human use. Vitamin K is presently listed in Part II of Schedule F.
Vitamin K is not a single chemical entity. The term "vitamin K" refers to a group of compounds known as vitamins K1, K2, K3, K4 and K5. Vitamin K1, also known as phylloquinone and phytonadione, is synthesized by plants. Vitamin K2 is usually derived from microbes and is also known as menaquinone and menatetrenone.
The Drug Schedule Status Committee determines prescription status for medicinal ingredients on the basis of established and publicly available criteria. These criteria include, but are not limited to, concerns related to toxicity, pharmacological properties, and therapeutic applications.
Non-prescription status for Vitamin K1 and K2 at 120 micrograms or less for oral use
Vitamin K1 and K2 are the major dietary forms of vitamin K. The creation of non-prescription status for vitamin K1 and K2 in oral dosage forms when the maximum recommended daily dose is 120 micrograms or less is based on an evaluation of safety data and a review of the approaches used in other regulatory jurisdictions.
Other considerations
No adverse effects associated with vitamin K1 or K2 consumption from food or supplements have been reported in humans or animals at the recommended level of 120 micrograms per day or less. A comprehensive search of the literature revealed no evidence of toxicity associated with the intake of vitamin K1 or K2 at the level of 120 micrograms per day.
Many regulatory jurisdictions permit vitamin K below certain maximum daily doses to be sold as either a nonprescription drug or, as in the United States, a dietary supplement. The maximum recommended daily dose of 120 micrograms falls within the international range of levels (40 - 130 micrograms) not requiring a prescription.
The factors for placing a substance on Schedule F no longer apply to the oral dosage forms of vitamin K1 and K2 when the maximum daily dose recommended on the product label does not exceed 120 micrograms.
Alternative
The alternative option would have been to maintain the status quo; that is, not to allow nonprescription status for vitamin K1 and K2 in oral dosage forms when the maximum recommended daily dose is equal to or less than 120 micrograms. Retaining complete prescription status for vitamin K1 and K2 is not an appropriate risk management approach. The benefits of having vitamin K1 and K2 in oral dosage forms as a nonprescription drug clearly outweigh the risks, when the maximum recommended daily dose is 120 micrograms or less.
Nonprescription status for Vitamin K1 and K2 in products for external use in humans
This amendment also removes from Schedule F vitamin K1 and K2 when included as a medicinal ingredient in products for external use in humans. Initially, the prescription requirement for vitamin K and several other vitamins was stated only in Division 4 of Part D of the Food and Drug Regulations and pertained only to drugs for internal or parenteral use in humans. When vitamin K was added to Schedule F, an oversight occurred, and no qualifying wording was added to indicate that only vitamin K for internal or parenteral use required a prescription. Without qualification, all dosage forms of vitamin K, including topical products, required prescription status.
Alternative
The alternative option would have been to maintain the status quo; that is, not to allow nonprescription status for vitamin K1 and K2 in products intended for external use in humans. This option was not considered to be appropriate, as the safety profile of vitamin K1 and K2 in these products is consistent with other non-prescription products.
Addition of Vitamin K1 and K2 to the Natural Health Products Regulations
This amendment adds vitamin K1 and K2 to item 3 of Schedule 1 to the Natural Health Products Regulations. Schedule 1 of the Regulations sets out the substances that are natural health products providing they meet the definition of natural health product in the Natural Health Products Regulations.
When the Natural Health Product Regulations were first proposed, it was intended that vitamin K be contained in Schedule 1 to those Regulations. However, the listing of vitamin K in Schedule F to the Food and Drug Regulations was an impediment to the inclusion of vitamin K in the Natural Health Product Regulations, because, by virtue of subsection 2(2) of the Natural Health Product Regulations, a substance that is required to be sold pursuant to a prescription is not considered a natural health product. The amendment to Schedule F to the Food and Drug Regulations permits the related amendment to Schedule 1 to the Natural Health Product Regulations.
Alternative
Within the Natural Health Product Regulations, the alternative option would have been to maintain the status quo; that is, not to include vitamin K1 and K2 on Schedule 1. This option was not considered to be an appropriate risk management approach, since the Drug Schedule Status Committee has determined that the non-prescription sale of oral dosage forms of vitamin K1 and K2 below a certain level and vitamin K1 and K2 in products intended for external use is acceptable.

Everyone is entitled to be stupid, but some abuse the privilege.